Courses List

0
No products in the cart.
← Literature Database

A low or high BMI is a risk factor for renal hematoma after extracorporeal shock wave lithotripsy for kidney stones.

Practice Point

Fabio Nussberger, Beat Roth, Tobias Metzger, Bernhard Kiss, George N Thalmann, Roland Seiler

Urolithiasis · 2017 · Vol. 45 · Issue 3 · 317-321

PMID: 27576325 DOI: 10.1007/s00240-016-0915-4

Academy Summary

Nussberger and colleagues investigated potential risk factors for renal haematoma following SWL for kidney stones.

Between June 2010 and March 2013, 418 patients underwent renal SWL using the MODULITH SLX-F2 lithotripter.

All patients underwent ultrasound examination on the first day after treatment. Renal haematomas were detected in 39 of 418 patients, approximately 9%.

For 37 patients with haematoma, the investigators identified matched controls without haematoma. Matching included:

Age

Sex

Number of shock waves

Shock-wave energy

Stone burden

Stone location

The investigators then compared additional possible risk factors between the two groups.

Diabetes, arterial hypertension, and appropriately discontinued anticoagulant or antiplatelet treatment were not significantly different between the groups.

Skin-to-kidney distance was also essentially identical.

BMI, however, showed a significant relationship.

A BMI above 30 was considerably more common among patients who developed haematoma.

Very low BMI, defined in this study as below 21.5, was also associated with haematoma. All four patients in this BMI category developed a renal haematoma.

The investigators therefore proposed that both high and low BMI may represent risk factors for renal injury following SWL.

Unlock the Academy Interpretation for Free

Create a free Lithotripsy Academy account or log in to access the complete Academy interpretation, including Key Findings, Clinical Takeaway, Limitations, and Expert Commentary

Subscribe to View Details Already a member? Log in
Comments & Discussion0 comments

Discuss the publication's evidence, limitations and practical relevance. Please do not include identifiable patient information or individual medical advice.

No comments yet. Start the discussion.